ICN Pharmaceuticals Inc.: The Costa Mesa firm,...
- Share via
From Times Staff and Wire Reports
ICN Pharmaceuticals Inc.: The Costa Mesa firm, which makes drugs and medical diagnostic products and engages in biotechnology research, said its third-quarter loss of $5.5 million was more than double its loss in the same quarter a year ago. Sales rose 47% to $63 million. The company said unfavorable currency exchange adjustments lowered its results.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
